Accelerate your company’s commercialization journey with accelerated compliance programs and digital transformation. 

Fast growing pre-commercial or newly commercialized biotechs, pharmaceutical, and medical device companies with innovative technologies are undergoing massive process, technical, and cultural changes. USDM’s Emerging Life Sciences division helps hundreds of pre-commercial Life Sciences customers reach commercialization faster. We are experts at developing right-size, phase appropriate, pragmatic quality and IT compliance programs. We also have expertise in RAPIDLY implementing dozens of quality, content, and clinical cloud systems by leveraging pre-packaged accelerators, like Cloud Assurance for managing your post go-live cloud changes, and Organizational Change Management to make our customers streamlined and compliance focused. 


We help our customers:

  • Accelerate Technology Roadmaps
  • Accelerate Process Maturity   
  • Accelerate Regulatory Readiness
  • Accelerate Service Delivery

Areas of Focus

Emerging/Start-ups/R&D

Sorry, no matches found.

Thought Leaders

Leading experts in Emerging Start-ups

Learn More

We use cookies to understand how you use our site and improve your experience. This includes personalizing content and advertising. Learn more.